Serum DcR2 has been proposed as a prognostic marker in prostate cancer [14], and urinary DcR2 (uDcR2) levels have been positively correlated with renal fibrosis in CKD [15, 16]. This evidence concerns the gene TNFRSF10D and chronic kidney disease.